大健康行业周报 |13亿,“中国美敦力”完成交割;东星医疗:拟以支付现金方式购买武汉医佳宝90%的股权

保观
Sep 29, 2025

保观 |聚焦保险创新国内篇行业动态13亿,“中国美敦力”完成交割近日,上海生物医药并购基金携手浦东创投集团旗下引领区基金,完成收购日本大冢集团所持微创医疗股份的交割,交易金额达13亿元人民币,上海生物医药并购基金成为微创医疗重要战略股东,持股约7.3%。此次交割完成后,被视为“中国美敦力”的微创医疗股价在港股市场表现活跃,市值突破200亿港元。此次交易体现了上海国资平台的协同作战优势,上实集团与...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10